# Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds

> **NCT03033862** · — · WITHDRAWN · sponsor: **Inova Health Care Services**

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Bioresorbable Vascular Scaffold
- **DEVICE:** Drug Eluting Stent

## Key facts

- **NCT ID:** NCT03033862
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-07-01
- **Primary completion:** 2017-07-01
- **Final completion:** 2017-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Stent taken off market due to safety concerns
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033862, "Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03033862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*